Invasion, control and persistence of Leishmania parasites (Q41103031)

26 September 2017

1 reference

title

Invasion, control and persistence of Leishmania parasites (English)

1 reference

26 September 2017

Bogdan C

1

1 reference

26 September 2017

Gessner A

series ordinal

2

1 reference

26 September 2017

Solbach W

series ordinal

3

1 reference

26 September 2017

Röllinghoff M

series ordinal

4

1 reference

26 September 2017

1 August 1996

1 reference

Current Opinion in Immunology

26 September 2017

1 reference

26 September 2017

8

1 reference

26 September 2017

4

1 reference

26 September 2017

517-525

1 reference

The regulation of immunity to Leishmania major

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Recurrent cutaneous leishmaniasis: a role for persistent parasites?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Stage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Lipophosphoglycan blocks attachment of Leishmania major amastigotes to macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Murine epidermal Langerhans cells do not express inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Isolation and structural characterization of the Leishmania donovani kinetoplastid membrane protein-11, a major immunoreactive membrane glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Interleukin‐10 differentially regulates B7‐1 (CD80) and B7‐2 (CD86) expression on human peripheral blood dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Costimulation and the regulation of antimicrobial immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Expression cloning of a protective Leishmania antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Recombinant interleukin 12 cures mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

CD40 ligand is required for protective cell-mediated immunity to Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Altered immune responses in mice lacking inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

L-N6-(1-iminoethyl)-lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Lack of inducible nitric oxide synthase activity in T cell clones and T lymphocytes from naive and Leishmania major-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Susceptibility to Leishmania major infection in interleukin-4-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB/c x C57BL/6) F1 mice infected with Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

T cell and non-T cell compartments can independently determine resistance to Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Early parasite containment is decisive for resistance to Leishmania major infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

In susceptible mice, Leishmania major induce very rapid interleukin-4 production by CD4+ T cells which are NK1.1-

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

T cell genetic background determines default T helper phenotype development in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980040-9

7 January 2021

10.1016/S0952-7915(96)80040-9

Identifiers

DOI

1 reference

26 September 2017

1 reference